Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01596751||Active, not recruiting||Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer||
||Other / Industry||
||68||All||18 Years and older (Adult, Older Adult)||NCT01596751||UCSF Protocol No. 12751||July 2012||July 5, 2017||December 2020||May 11, 2012||May 31, 2018||